416 related articles for article (PubMed ID: 33911856)
21. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.
Lv Y; Zhao X; Wang Y; Zhu J; Ma C; Feng X; Ma Y; Zheng Y; Yang L; Han G; Xie H
Front Med (Lausanne); 2021; 8():639855. PubMed ID: 34179034
[No Abstract] [Full Text] [Related]
22. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
[TBL] [Abstract][Full Text] [Related]
23. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.
Mendizabal M; Piñero F; Ridruejo E; Anders M; Silveyra MD; Torre A; Montes P; Urzúa A; Pages J; Toro LG; Díaz J; Gonzalez Ballerga E; Miranda-Zazueta G; Peralta M; Gutiérrez I; Michelato D; Venturelli MG; Varón A; Vera-Pozo E; Tagle M; García M; Tassara A; Brutti J; Ruiz García S; Bustios C; Escajadillo N; Macias Y; Higuera-de la Tijera F; Gómez AJ; Dominguez A; Castillo-Barradas M; Contreras F; Scarpin A; Schinoni MI; Toledo C; Girala M; Mainardi V; Sanchez A; Bessone F; Rubinstein F; Silva MO
Ann Hepatol; 2021; 21():100298. PubMed ID: 33359234
[TBL] [Abstract][Full Text] [Related]
24. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
Wu Y; Li H; Guo X; Yoshida EM; Mendez-Sanchez N; Levi Sandri GB; Teschke R; Romeiro FG; Shukla A; Qi X
Hepatol Int; 2020 Sep; 14(5):621-637. PubMed ID: 32710250
[TBL] [Abstract][Full Text] [Related]
25. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.
Zhang Y; Zheng L; Liu L; Zhao M; Xiao J; Zhao Q
Liver Int; 2020 Sep; 40(9):2095-2103. PubMed ID: 32239796
[TBL] [Abstract][Full Text] [Related]
26. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients.
Paštrovic F; Lucijanic M; Atic A; Stojic J; Barisic Jaman M; Tjesic Drinkovic I; Zelenika M; Milosevic M; Medic B; Loncar J; Mijic M; Filipec Kanizaj T; Kralj D; Lerotic I; Virovic Jukic L; Ljubicic N; Luetic K; Grgic D; Majerovic M; Ostojic R; Krznaric Z; Luksic I; Piskac Zivkovic N; Keres T; Grabovac V; Persec J; Barsic B; Grgurevic I
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575333
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
Li T; Deng C; Du Q; Yue R; Lu S; Chen H; Guo Y; Huang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):928-932. PubMed ID: 32912404
[TBL] [Abstract][Full Text] [Related]
29. Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study.
Suresh S; Siddiqui M; Abu Ghanimeh M; Jou J; Simmer S; Mendiratta V; Russell S; Al-Shammari M; Chatfield A; Alsheik E; Dang D; Genaw J; Zuchelli T
Obes Res Clin Pract; 2021; 15(2):172-176. PubMed ID: 33653666
[TBL] [Abstract][Full Text] [Related]
30. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
Hakeam HA; Alsemari M; Duhailib ZA; Ghonem L; Alharbi SA; Almutairy E; Sheraim NMB; Alsalhi M; Alhijji A; AlQahtani S; Khalid M; Barry M
J Cardiovasc Pharmacol Ther; 2021 May; 26(3):244-252. PubMed ID: 33231487
[TBL] [Abstract][Full Text] [Related]
31. Association of liver abnormalities with in-hospital mortality in patients with COVID-19.
Ding ZY; Li GX; Chen L; Shu C; Song J; Wang W; Wang YW; Chen Q; Jin GN; Liu TT; Liang JN; Zhu P; Zhu W; Li Y; Zhang BH; Feng H; Zhang WG; Yin ZY; Yu WK; Yang Y; Zhang HQ; Tang ZP; Wang H; Hu JB; Liu JH; Yin P; Chen XP; Zhang B;
J Hepatol; 2021 Jun; 74(6):1295-1302. PubMed ID: 33347952
[TBL] [Abstract][Full Text] [Related]
32. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
[TBL] [Abstract][Full Text] [Related]
33. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
34. Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients.
Mushtaq J; Pennella R; Lavalle S; Colarieti A; Steidler S; Martinenghi CMA; Palumbo D; Esposito A; Rovere-Querini P; Tresoldi M; Landoni G; Ciceri F; Zangrillo A; De Cobelli F
Eur Radiol; 2021 Mar; 31(3):1770-1779. PubMed ID: 32945968
[TBL] [Abstract][Full Text] [Related]
35. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
36. Acute Liver Injury in Patients Hospitalized with COVID-19.
Sobotka LA; Esteban J; Volk ML; Elmunzer BJ; Rockey DC;
Dig Dis Sci; 2022 Aug; 67(8):4204-4214. PubMed ID: 34487314
[TBL] [Abstract][Full Text] [Related]
37. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.
Li T; Guo Y; Zhuang X; Huang L; Zhang X; Wei F; Yang B
Saudi J Gastroenterol; 2020; 26(5):272-278. PubMed ID: 32769260
[TBL] [Abstract][Full Text] [Related]
38. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain.
Benedé-Ubieto R; Estévez-Vázquez O; Flores-Perojo V; Macías-Rodríguez RU; Ruiz-Margáin A; Martínez-Naves E; Regueiro JR; Ávila MA; Trautwein C; Bañares R; Bosch J; Cubero FJ; Nevzorova YA
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33802486
[TBL] [Abstract][Full Text] [Related]
39. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
